This EUPATI Mini-course starter kit is designed for patient involvement in medicines safety.
EUPATI Mini-course starter kits have been derived from content found in the EUPATI toolbox and EUPATI Patient Expert Training Course. The starter kits are thought to address roles that patients play in medicines development for example those shown in the figure below.
The starter kits provide you with links to relevant background reading in the toolbox and associated PowerPoint slide decks and media in order to prepare a single or multi-day training on the subject. Each of the starter kits contains a selection of PPT slides which you may use to educate patients/advocates about the “basics” in that area, e.g. in a two-hour to one-day seminar.
The starter kits are based on existing content from the EUPATI Toolbox, plus additional links to add-on Toolbox material. None of the “starter kits” are “ready-made course” modules – they are a ready-to-reuse resource for an experienced trainer to prepare and execute a course. You will need to edit them and put them into context.
Before you begin please download and review the ‘Manual for Trainers’.
- Presentation: Manual for Trainers
Size: 722,143 bytes, Format: .pptx
A manual for trainers describing how to use the EUPATI mini-course starter kits to create trainings on patient involvement.
This starter kit provides background reading, slides, and quizzes to create training for patients who intend to become involved in medicines safety.
Pharmacovigilance: monitoring the safety of medicines (coming soon)
- Presentation: Efficacy and Safety of Medicines
Size: 373,525 bytes, Format: .pptx
A presentation describing the efficacy and safety of medicines, which can be adapted for own use.
- Presentation: Principles of Risk Management
Size: 372,303 bytes, Format: .pptx
A presentation describing the principles of risk management, which can be adapted for own use.
- Presentation: EudraVigilance
Size: 372,115 bytes, Format: .pptx
A presentation describing the EudraVigilance information system, which can be adapted for own use.
- Presentation: Risk Communication in Medicines
Size: 495,341 bytes, Format: .pptx
A presentation describing risk communication process in medicines, which can be adapted for own use.
- Presentation: Information on Medicinal Products
Size: 547,126 bytes, Format: .pptx
A presentation describing the information in medicinal products, which can be adapted for own use.
- Presentation: Generic Medicines
Size: 362,039 bytes, Format: .pptx
A presentation describing generic medicines, which can be adapted for own use.
- Quizzes will be provided for each presentation in the future on:
- Efficacy and safety of medicines
- Pharmacovigilance: Monitoring the safety of medicines
- Principles of risk management
- Risk Communication in medicines
- Information on medicinal products
- Generic medicines
Remember that all educational content provided by EUPATI is released under a Creative Commons License, which also applies to all derivatives of it! Therefore
- you must state the license in your course material.
- you must also release your course material under Creative Commons when using EUPATI material.
Example of how to reference material if you have changed something:
“My clinical trials guide” is a derivative of “Phases of Clinical Development” by EUPATI used under CC BY-NC-SA 4.0. “My clinical trials guide” is licensed under CC BY-NC-SA 4.0 by Matthew.
Use of the EUPATI logo
The EUPATI logo is protected by trademark and owned by the European Patients Forum.
Except for the limited purpose of indicating that work is created or licensed by EUPATI (European Patients Academy for Therapeutic Innovation), or collaboration with EUPATI, the European Patients Forum (EPF) does not authorise the use, by any party, of the trademark "EUPATI" or any related trademark or logo of EUPATI without the prior written consent of EPF. Any permitted use will be in compliance with EUPATI's then-current trademark usage guidelines, as may be published on its website or otherwise made available upon request from time to time.